2020 MIPS Extreme and Uncontrollable Circumstances Exception Application Deadline for COVID-19 has been Extended to February 1, 2021

• 24/12/2020
• Posted By: John Aldover

Extreme and Uncontrollable Circumstances Application To further support clinicians during the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services (CMS) has extended the deadline for COVID-19 related 2020 Merit-based Incentive Payment System (MIPS) Extreme and Uncontrollable Circumstances Exception applications to February 1, 2021. For the 2020 performance...

ICD-10 Code Files for FY 2021

• 24/12/2020
• Posted By: John Aldover

In response to the COVID-19 public health emergency, new ICD-10 codes are effective January 1: 21 procedure codes (ICD-10-PCS): CMS will implement new codes to describe the introduction or infusion of therapeutics, including monoclonal antibodies and vaccines for COVID-19 treatment 6 diagnosis codes (ICD-10-CM): CDC National Center for Health...

COVID-19 Vaccine Codes: Updated Effective Date for Moderna

• 22/12/2020
• Posted By: John Aldover

On December 18, 2020, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the Moderna COVID‑19 Vaccine for the prevention of COVID-19 for individuals 18 years of age and older. Review Moderna’s Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) regarding the limitations of...

COVID-19 Vaccine Codes: Updated Effective Date for Pfizer-BioNTech

• 15/12/2020
• Posted By: John Aldover

On December 11, 2020, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID‑19 Vaccine for the prevention of COVID-19 for individuals 16 years of age and older. Review Pfizer’s Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) regarding the limitations of authorized...

Entry-Level Warehouse Associate

• 08/12/2020
• Posted By: John Aldover

CMS Takes Steps to Ensure Medicare Beneficiaries Have Wide Access to COVID-19 Antibody Treatment

• 13/11/2020
• Posted By: John Aldover

Coverage Available at No Cost to Beneficiaries Across Variety of Settings in Health Care System CMS announced that starting November 10, Medicare beneficiaries can receive coverage of monoclonal antibodies to treat COVID-19 with no cost-sharing during the Public Health Emergency (PHE). CMS coverage of monoclonal antibody infusions applies to bamlanivimab,...

Software and Services Sales Representative

• 22/10/2020
• Posted By: John Aldover